Published in Mental Health Business Week, February 4th, 2006
"This is being touted as the beginning of personalized medicine," Stephen C. Peiper, chair of the MCG Department of Pathology says of the first U.S. Food & Drug Administration (FDA)-cleared pharmacogenetics test that looks at how an individual metabolizes a drug.
"We are talking about a chip-based genetic test that looks at differences between individuals," Peiper says of the AmpliChip CYP450 Test, developed by Roche Diagnostics, which analyzes variations of the two major genes involved...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.